3Q17 Botox addendum: The US-therapeutic figure of $368.9M in #msg-135855769 includes $16.8M of US sales for hyperhidrosis. (AGN’s PR lists the US hyperhidrosis sales separately from other US therapeutic sales.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”